Thus, exercise-triggered adipocyte- and/or monocyte/macrophage-specific PPARγ activation may constitute an additional rationale for prescribing exercise in obesity and type 2 diabetes. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.